Exane Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Exane Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,700	Closed	-$604K	–	98
2018 Q4	$604K	Sell	2,700 -700	-21%	-$164K	0.35%	36
2018 Q3	$830K	Buy	+3,400	New	+$782K	0.26%	48
2018 Q2	–	Sell	-3,200	Closed	-$661K	–	168
2018 Q1	$661K	Buy	3,200 +1,800	+129%	+$378K	0.2%	48
2017 Q4	$266K	Buy	1,400 +700	+100%	+$134K	0.08%	40
2017 Q3	$132K	Sell	700 -700	-50%	-$127K	0.03%	90
2017 Q2	$244K	Buy	+1,400	New	+$235K	0.08%	47

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Exane Asset Management's TMO Position: Q1 2019 in Review

Exane Asset Management sold out of Thermo Fisher Scientific (TMO) in Q1 2019, closing a stake of 2,700 shares — an estimated $604K sold.

Exane Asset Management first reported a position in TMO in Q2 2017 and held it in 6 quarters. The position peaked at $830K in Q3 2018. 1,522 funds tracked by Wall St. Rank hold TMO as of Q1 2019.

Exane Asset Management reported no remaining Thermo Fisher Scientific position as of Q1 2019 after selling out during the quarter.
Exane Asset Management sold 2,700 Thermo Fisher Scientific shares in Q1 2019, an estimated $604K.
Exane Asset Management first reported a position in Thermo Fisher Scientific in Q2 2017 and held it in 6 quarters.
Exane Asset Management's Thermo Fisher Scientific position peaked at $830K in Q3 2018.
1,522 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2019.

Based on Exane Asset Management's 13F filing for Q1 2019, filed 7 May 2019.